œŽ@–¼
  ¼–{@ŒõŽi
  Koji MATSUMOTO
   
œŠ@‘®
  ’}”g‘åŠw@‘åŠw‰@@
lŠÔ‘‡‰ÈŠwŒ¤‹†‰Èi —Õ°ˆãŠwŒn j@
޾г§ŒäˆãŠwêU @
•wlŽüŽYŠúˆãŠw•ª–ì @
   
œE@–¼
  y‹³Žö
   
œŠw@ˆÊ
  ˆãŠw”ŽŽm ( “Œ‹ž‘åŠw )
   
œê–啪–ì
  •wl‰ÈŽîᇊw
   
œŒ¤‹†ƒe[ƒ}
 

ƒqƒgƒpƒsƒ[ƒ}ƒEƒCƒ‹ƒX (HPV) ‚ÆŽq‹{èòŠà

   
œŠ‘®Šw‰ïEŠw‰ï–ðˆõ
 

E“ú–{ŽY‰È•wl‰ÈŠw‰ï
E“ú–{•wl‰ÈŽîᇊw‰ï
E“ú–{ŠàŽ¡—Êw‰ï
E“ú–{ŠàŠw‰ï

   
œ’˜‘E˜_•¶
  Matsumoto K et al: IgG antibodies to HPV16, 52, 58 and 6 L1-capsids and spontaneous regression of cervical intraepithelial neoplasia. Cancer Lett , 231:309-313, 2006.
 

Matsumoto K et al: Impaired antigen presentation and effectiveness of combined active/passive immunotherapy for epithelial tumors. J Natl Cancer Inst , 96:1611-1619, 2004.

  Matsumoto K et al: Are smoking and chlamydial infection risk factors for CIN? Different results after adjustment for HPV DNA and antibodies. Br J Cancer , 89:831-833, 2003.
  Matsumoto K et al: Human papillomavirus type 16 E6 variants and HLA class II alleles among Japanese women with cervical cancer. Int J Cancer , 106;919-922, 2003.
  Matsumoto K et al: IgG antibodies to human papillomavirus 16, 52, 58, and 6 L1 capsids: case-control study of cervical intraepithelial neoplasia in Japan . J Med Virol , 69;441-416, 2003
   
œŠwpŠÖŒWŽóÜ
   
   
œtelEfax
  tel : 029-853- 3073
  fax : 029-853- 3072
   
œƒ[ƒ‹ƒAƒhƒŒƒX
  matsumokmui.biglobe.ne.jp

[—ª—ð]
1991.3
“Œ‹ž‘åŠwˆãŠw•”ˆãŠw‰È‘²‹Æ
1998.5
“Œ‹ž‘åŠwˆãŠw•”•‘®•a‰@ŽY•wl‰È@•Žè
2001.9 - 2003.12
‹BƒNƒB[ƒ“ƒYƒ‰ƒ“ƒh‘åŠw—¯Šw@‹qˆõŒ¤‹†ˆõ
2005.9
’}”g‘åŠw‘åŠw‰@lŠÔ‘‡‰ÈŠwŒ¤‹†‰È@uŽt